Skip to content
Retatrutide

Retatrutide 45mg Imported

Retatrutide 45 mg vial with a Bacteriostatic Water vial

฿3,190
Size

Sold out

Ask on LINE
Genuine imported stock, lot-checked before shipping
EMS delivery in Thailand 60 THB, dispatched once payment is confirmed
Product warranty

Record an unboxing video every time, from before you open the parcel until it is unpacked, in one uncut take. Without the video, no claim can be accepted.

You can claim

  • A product that arrives broken, damaged or missing
  • The wrong product, still unopened
  • An opened product, only when the item inside is cracked or broken

No claim

  • An opened product in normal condition
  • More than 7 days after delivery without an unboxing video

What is Retatrutide 45mg?

Retatrutide 45 mg is an injectable set whose box prints Retatrutide Injection 45 mg/2 mL, with a retatrutide 45 mg vial and a diluent vial.

In short

  • The set holds two vials: one printed Retatrutide 45mg 1 Vial, and one of Bacteriostatic Water for injection, a Multiple-Dose Vial for diluent use only.
  • ClinicalTrials.gov lists Eli Lilly's TRIUMPH-1 study (NCT05929066) in people with obesity or overweight, which uses subcutaneous retatrutide.
  • The 45 mg strength belongs to retatrutide alone and is not a basis for comparison across substances or brands.

What to tell the doctor before considering it

The doctor judges whether it should be used, from your health history, current medicines, allergies, and any pregnancy or breastfeeding.

Tell the doctor how the product in hand prints its name and strength, and ask which symptoms mean you should get back in touch after treatment.

Storage and preparation

Store and prepare it as the vial label and the doctor or pharmacist direct, and keep it in its original packaging until the clinic uses it.

Frequently asked questions

What is retatrutide?

Retatrutide (LY3437943) is a substance that a 2023 phase 2 trial report in NEJM describes as a GIP, GLP-1 and glucagon receptor agonist.

Is retatrutide peptide approved yet?

No. The FDA states that retatrutide is not a component of any FDA-approved drug and has not been shown to be safe and effective for any condition. Talk to a doctor before considering a product printed with this substance.

How does retatrutide differ from tirzepatide?

Tirzepatide activates the GIP and GLP-1 receptors and is in the FDA-approved drug Mounjaro. Retatrutide activates the glucagon receptor as well.

Who prepares and gives retatrutide?

A licensed doctor prepares the substance with the diluent and sets how it is used. People should not mix it themselves or follow someone else's experience.

How much is Retatrutide 45 mg?

The price depends on the model and the quantity.

References

  1. FDA's Concerns with Unapproved GLP-1 Drugs Used for Weight Loss. U.S. Food and Drug Administration (2026) fda.gov/drugs/drug-alerts-and-statements/fdas-concerns-unapproved-glp-1-drugs-used-weight-loss(opens in a new tab)
  2. A Study of Retatrutide (LY3437943) in Participants Who Have Obesity or Overweight (TRIUMPH-1), NCT05929066. ClinicalTrials.gov, sponsor Eli Lilly and Company (2026) clinicaltrials.gov/study/NCT05929066(opens in a new tab)
  3. Triple-Hormone-Receptor Agonist Retatrutide for Obesity - A Phase 2 Trial. The New England Journal of Medicine (2023) doi.org/10.1056/NEJMoa2301972(opens in a new tab)

This information is for general knowledge and does not replace a doctor's advice. Every procedure should be performed by a licensed doctor in a medical facility.

You may also like

Shop all